Comparative Evaluation of Various Combinable Magnetic Resonance (CMR) Pulse-sequences for Macrophage Imaging Using Ferucarbotran

NCT00886444 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Acute Myocardial Infarction

Interventions

DRUG: Ferucarbotran (Resovist)

Sponsor

Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)